Navigation Links
Velcade (bortezomib) for Injection Based Therapies Achieved,Survival Rates as High as 100 Percent in Newly Diagnosed Multiple,Myeloma Patients

-- 100 percent response rate achieved with VELCADE, lenalidomide and dexamethasone

KOS, Greece, June 28 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) today reported on the presentation of results from four clinical trials of VELCADE based therapies that showed consistently high survival and complete remission / complete response(1) (CR) rates in newly diagnosed multiple myeloma (MM) patients. These data were presented at the prestigious 11th International Myeloma Workshop (IMW) in Kos, Greece. Highlights included:

(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )

-- VELCADE, melphalan and prednisone (VMP) demonstrated a CR(1) rate of 43 percent, the strongest rate ever reported for a melphalan prednisone combination therapy. At 38 months, 85 percent of patients were alive. This is the highest reported three-year survival rate in the front-line treatment setting.

-- VELCADE, adriamycin and dexamethasone (referred to as VcAD or PAD) showed a CR(1) rate of 29 percent prior to stem cell transplantation (SCT), which further improved to 57 percent following SCT. At one year, 100 percent of patients were alive, and at two years, 95 percent of patients were alive. This is the highest reported two-year survival rate in the front-line treatment setting. Median overall survival (OS) has not yet been reached after four years.

-- VELCADE, DOXIL(R) (pegylated liposomal doxorubicin) and dexamethasone (VDD) showed a CR(1) rate of 43 percent prior to SCT, which increased to 65 percent following SCT. At 16 months, 100 percent of patients were alive.

-- VELCADE, lenalidomide and dexamethasone (VRD) showed an overall res
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
2. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
3. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
4. Study Shows Velcade Plus Doxil Improves Survival in Previously Treated Patients With Multiple Myeloma
5. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
6. Millennium Discovers Biomarkers Potentially Predictive of Response to Velcade (Bortezomib) for Injection
7. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
8. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
9. Genta Announces Results of Phase 1 Study Using Genasense Administered by Intermittent Subcutaneous Injection
10. Aquavan (Fospropofol Disodium) Injection Data Presented at Digestive Disease Week 2007
11. Hana Biosciences Announces Data to be Presented On Talvesta (Talotrexin) for Injection at The American Association for Cancer Research Annual Meeting
Post Your Comments:
(Date:7/23/2014)... , July 23, 2014  Essentialis announced ... Foundation for Prader-Willi Research (FPWR) to support clinical ... safety and efficacy of diazoxide choline controlled release ... study is being conducted at the University of ... Virginia Kimonis . "We have found ...
(Date:7/23/2014)... -- Sinovac Biotech Ltd. (NASDAQ: SVA ), a ... , announced today that it has been selected by the ... be a supplier of the seasonal influenza vaccine to the ... The Beijing CDC plans to order a minimum of ... from four domestic vaccine manufacturers for its vaccination campaign. Each ...
(Date:7/23/2014)... , July 23, 2014 Research ... the "Emulsifiers - Global Strategic Business Report" ... http://photos.prnewswire.com/prnh/20130307/600769 This report ... Tons and US$ Thousands by the following Product ... Sucroglycerides, Polysorbates and Sorbitan Esters, and Polyglycin Polyricinoleate ...
Breaking Medicine Technology:Essentialis Secures Foundation for Prader-Willi Research Grant to Help Advance DCCR in the Treatment of Prader-Willi Syndrome 2Sinovac Receives Beijing CDC Tender to Supply Seasonal Flu Vaccine Anflu 2Emulsifiers - Global Strategic Business Report: Updated 2014 Report 2Emulsifiers - Global Strategic Business Report: Updated 2014 Report 3
... LAKE FOREST, Ill., Feb. 14, 2011 Hospira, Inc. (NYSE: ... delivery company, today announced that the company will present at ... Institutional Investors Conference March 8, 2011 ... Barclays Capital 2011 Global Healthcare Conference ...
... Calif., Feb. 14, 2011 / PRNewswire/ -- ... a $22 million Series D financing round led by ... were Split Rock Partners, Legacy Life Sciences, EDF Ventures, ... Asset Management Partners.  In connection with the financing, Dr. ...
Cached Medicine Technology:Sonoma Orthopedic Products® Closes $22 Million Series D Financing 2
(Date:7/23/2014)... (PRWEB) July 23, 2014 “I believe that ... Patricia Bragg, longtime spokesperson for Bragg Live Foods, whose products ... expressed this opinion on the Sharon Kleyne Hour Power of ... advocate attributed the toxicity to big business farming, consumer demand ... spokesperson for Bragg Live Foods and daughter-in-law of Paul Bragg, ...
(Date:7/23/2014)... CO (PRWEB) July 23, 2014 Daily Face ... a cheaper and safer alternative to Botox called Stem ... Serum is an anti-aging product used to help people smooth, ... Facial Serum can be used as a safe alternative to ... not have any toxins or health risks as opposed to ...
(Date:7/23/2014)... 23, 2014 Low enrollment and ... exchanges to come up with alternative means to ... myriad ways to accomplish this in the July ... Insurance Exchanges (HEX). , “We never expected the ... exchanges, Christopher Condeluci, an attorney at the law ...
(Date:7/23/2014)... July 23, 2014 Washington, DC’s long ... the first time this Saturday. This expansion to the ... for the massively expanding Tysons area, located just outside ... Washington, DC help local area growth, but it will ... the nation’s capital and its surrounding areas. , “We ...
(Date:7/23/2014)... 23, 2014 Woodland Hills’ top cosmetic ... from chronic bad breath that the condition is more than ... Dr. Saj Jivraj and Dr. Mamaly Reshad of the Anacapa ... concerned that some people may be overlooking an obvious sign ... sign of an infection or chronic disease in the body,” ...
Breaking Medicine News(10 mins):Health News:U.S. Farms Toxic Says Health Food Pioneer on Sharon Kleyne Hour Power of Water 2Health News:Local Denver Skin Care Company Releases Safer Alternative to Botox 2Health News:Industry Observers Tell AIS They Predict Changes to Exchange User Fees, Platforms 2Health News:Industry Observers Tell AIS They Predict Changes to Exchange User Fees, Platforms 3Health News:Washington, DC’s Metrorail Expansion Opening this Week Changes the Capital City’s Landscape for Locals and Visitors Alike 2Health News:Washington, DC’s Metrorail Expansion Opening this Week Changes the Capital City’s Landscape for Locals and Visitors Alike 3Health News:Washington, DC’s Metrorail Expansion Opening this Week Changes the Capital City’s Landscape for Locals and Visitors Alike 4Health News:Woodland Hills’ Top Cosmetic Dentists Offer 6 Tips on Causes of Bad Breath That Should Concern You 2Health News:Woodland Hills’ Top Cosmetic Dentists Offer 6 Tips on Causes of Bad Breath That Should Concern You 3Health News:Woodland Hills’ Top Cosmetic Dentists Offer 6 Tips on Causes of Bad Breath That Should Concern You 4Health News:Woodland Hills’ Top Cosmetic Dentists Offer 6 Tips on Causes of Bad Breath That Should Concern You 5
... care workers highlights connection between economic and health care crises ... WASHINGTON, Nov. 19 Pointing to the combined ... lives of working families nationwide, SEIU International President Andy ... in Washington today to work together to address the nation,s ...
... and Human Development Institute selects Teamworks BPM Suite to Manage Grants ... ... -- Lombardi®, a leader in business process management (BPM) ... of Child Health and Human Development (NICHD) , has selected its ...
... 19 PC Brands, a,California-based manufacturer of nutrition bars, ... are shelf stable all-natural bars. The,"on the go" ... that does not require refrigeration. , ... come in a 90-calorie Yogurt,Fruit and Nut with Cranberries, ...
... 19 November 2008] People who have attempted suicide at ... actually succeed in committing suicide at a later date. ... psychiatric disorder, according to a new study from the ... suicide attempters actually commit suicide later on in life. ...
... 19 , ... Decisions for,Increasing Both Safety and Productivity , ... performance in the European market,for hand protection solutions Frost ... Europe with the 2008 European Protective,Gloves Customer Service Leadership ...
... Nov. 19 High school athletes who drink ... some extra cash from got milk?(R) for,college. Today, ... with USA TODAY, launched the 12th annual Scholar ... The SAMMY Awards reward 25 high,school senior student ...
Cached Medicine News:Health News:SEIU's Andy Stern Renews Call to Fix Nation's Broken Health Care System, Ease Financial Strain on Working Families, Economy 2Health News:NICHD Deploying Lombardi Business Process Management (BPM) Suite 2Health News:NICHD Deploying Lombardi Business Process Management (BPM) Suite 3Health News:NICHD Deploying Lombardi Business Process Management (BPM) Suite 4Health News:PC Brands Introduces Great Tasting Shelf-Stable Nutrition Bar With Probiotics 2Health News:Ansell Healthcare Europe Lands 2008 Frost & Sullivan Customer Service Leadership Award for its Ansell Guardian(SM) Safety Program 2Health News:Teen Athletes Who Stay Fit With Milk Can Earn Cash for College 2
... disease ELISA products make us a leader ... for faster integration into the busy laboratory, ... reliability and run-to-run consistency. Our Infectious Disease ... a wide range of serological assays including ...
... Our breadth of infectious disease ELISA ... field. With standard assay protocols for faster ... Disease ELISA products provide increased reliability and ... includes antibody detection assays for a wide ...
... Our breadth of infectious disease ELISA products ... With standard assay protocols for faster integration ... ELISA products provide increased reliability and run-to-run ... antibody detection assays for a wide range ...
... infectious disease ELISA products make us a ... protocols for faster integration into the busy ... increased reliability and run-to-run consistency. Our Infectious ... for a wide range of serological assays ...
Medicine Products: